|
|
DSpace at RU >
Search Results
Results 1-18 of 18.
Item hits:
| Full Text | Issue Date | Title | Author(s) | | 2011 | Labor dystocia as First presentation of pelvic malignancy. | Hamont, D. van; Zusterzeel, P.L.M. |
| 2011 | Robot-assisted versus total laparoscopic radical hysterectomy in early cervical cancer, a review | Kruijdenberg, C.B.; Einden, L.C.G. van den; Hendriks, J.C.M.; Zusterzeel, P.L.M.; Bekkers, R.L.M. |
| 2011 | Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer | Yigit, R.; Figdor, C.G.; Zusterzeel, P.L.M.; Pots, J.M.; Torensma, R.; Massuger, L.F.A.G. |
| 2011 | External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses. | Akker, P.A. van den; Zusterzeel, P.L.M.; Aalders, A.L.; Snijders, M.P.; Samlal, R.A.; Vollebergh, J.H.A.; Kluivers, K.B.; Massuger, L.F.A.G. |
| 2011 | Factors influencing the use of frozen section analysis in adnexal masses | van den Akker, P.A.; Kluivers, K.B.; Aalders, A.L.; Snijders, M.P.; Samlal, R.A.; Vollebergh, J.H.A.; Zusterzeel, P.L.M.; Massuger, L.F.A.G. |
| 2011 | Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor | Yigit, R.; Massuger, L.F.A.G.; Zusterzeel, P.L.M.; Pots, J.M.; Figdor, C.G.; Torensma, R. |
| 2009 | Serum vascular endothelial growth factor: a prognostic factor in cervical cancer. | Zusterzeel, P.L.M.; Span, P.N.; Dijksterhuis, M.G.; Thomas, C.M.G.; Sweep, F.C.; Massuger, L.F.A.G. |
| 2009 | GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer. | Kolwijck, E.; Zusterzeel, P.L.M.; Roelofs, H.M.J.; Hendriks, J.C.M.; Peters, W.H.M.; Massuger, L.F.A.G. |
| 2008 | Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer. | Zusterzeel, P.L.M.; Bekkers, R.L.M.; Hendriks, J.C.M.; Neesham, D.N.; Rome, R.M.; Quinn, M.A. |
| 2007 | Susceptibility to pre-eclampsia is associated with multiple genetic polymorphisms in maternal biotransformation enzymes. | Zusterzeel, P.L.M.; Peters, W.H.M.; Burton, G.J.; Visser, W. de; Roelofs, H.M.J.; Steegers, E.A.P. |
| 2006 | Susceptibility to Pre-Eclampsia Is Associated with Multiple Genetic Polymorphisms in Maternal Biotransformation Enzymes. | Zusterzeel, P.L.M.; Peters, W.H.M.; Burton, G.J.; Visser, W.A.; Roelofs, H.M.J.; Steegers, E.A.P. |
| 2006 | Oral N-acetylcysteine administration does not stabilise the process of established severe preeclampsia. | Roes, E.M.; Raijmakers, M.; Boo, T.M. de; Zusterzeel, P.L.M.; Merkus, H.M.; Peters, W.H.M.; Steegers, E.A.P. |
| 2005 | N-acetyl-transferase phenotype and risk for preeclampsia. | Zusterzeel, P.L.M.; Morsche, R.H.M. te; Raijmakers, M.; Roes, E.M.; Peters, W.H.M.; Steegers-Theunissen, R.P.M.; Steegers, E.A.P. |
| 2004 | First trimester inhibin-A concentrations and later development of preeclampsia. | Roes, E.M.; Gaytant, M.A.; Thomas, C.M.G.; Raijmakers, M.; Zusterzeel, P.L.M.; Peters, W.H.M.; Steegers, E.A.P. |
| 2004 | Shift in expression of HLA-G mRNA spliceforms in pregnancies complicated by preeclampsia. | Emmer, P.M.; Joosten, I.; Schut, M.H.; Zusterzeel, P.L.M.; Hendriks, J.C.M.; Steegers, E.A.P. |
| 2004 | Thiol status and antioxidant capacity in women with a history of severe pre-eclampsia | Raijmakers, M.; Roes, E.M.; Zusterzeel, P.L.M.; Steegers, E.A.P.; Peters, W.H.M. |
| 2002 | Ethene and other biomarkers of oxidative stress in hypertensive disorders of pregnancy. | Zusterzeel, P.L.M.; Steegers-Theunissen, R.P.M.; Harren, F.J.M.; Stekkinger, E.; Kateman, H.; Timmerman, B.H.; Berkelmans, R.; Nieuwenhuizen, A.; Peters, W.H.M.; Raijmakers, M.; Steegers, E.A.P. |
| 1997 | Selective follicular reduction: what to do with the oocytes? | Zusterzeel, P.L.M.; Kremer, J.A.M.; Duijkers, I.J.M.; Coenen, C.M.H. |
1
|